4 recruiting, 1 active not recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 4, Active not recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow HER2-Negative Breast Carcinoma: new trials by email Literature Review of HER2-Negative Breast Carcinoma trials Research Report on HER2-Negative Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer Neoadjuvant Pembrolizumab, low dose neoadjuvant boost, High dose neoadjuvant boost - Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 32 | 2026-03-17 | 2026-04-27 |
| Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery Coriolus Versicolor Extract, Questionnaire Administration - Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 40 | 2024-10-25 | 2026-10-16 |
| Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial Cyclophosphamide, Docetaxel, Medical Chart Review - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | City of Hope Medical Center | 174 | 2024-09-16 | 2026-11-04 |
| Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer Biospecimen Collection, Computed Tomography, Gemcitabine - Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma | Phase 1 / Phase 2 | Recruiting | Margaret Gatti-Mays | 42 | 2024-04-02 | 2026-07-23 |
| Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca Accelerated Partial Breast Irradiation - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 2 | Active not recruiting | City of Hope Medical Center | 48 | 2023-09-29 | 2026-06-29 |
Breast Carcinoma In Situ (1) · Breast Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma in Situ (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Cyclophosphamide (1) · Docetaxel (1) · Gemcitabine (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · VPS Coriolus versicolor extract (1) · naxitamab (1)
City of Hope Medical Center (2) · Margaret Gatti-Mays (1) · Mayo Clinic (1) · UNC Lineberger Comprehensive Cancer Center (1)
United States (5)
Brenda J. Ernst, MD (1) · Dana Casey, MD (1) · Jose G Bazan (1) · Margaret E Gatti-Mays, MD MPH (1) · Thanh Nga E Doan, MD (1)
P30CA033572 (2), R01CA274254 (1)